Vitamin D nuclear receptor mediates the genomic actions of the active form of vitamin D, 1,25(OH) 2 D 3 . This hormone is involved in calcium and phosphate metabolism and cell differentiation. Compared to other nuclear receptors, VDR presents a large insertion region at the N-terminal part of the ligand binding domain between helices H1 and H3, encoded by an additional exon. This region is poorly conserved in VDR in different species and is not well ordered as observed by secondary structure prediction. We engineered a VDR ligand binding domain mutant by removing this insertion region. Here we report its biochemical and biophysical characterization. The mutant protein exhibits the same ligand binding, dimerization with retinoid X receptor and transactivation properties as the wild-type VDR, suggesting that the insertion region does not affect these main functions. Solution studies by small angle X-ray scattering shows that the conformation in solution of the VDR mutant is similar to that observed in the crystal and that the insertion region in the VDR wildtype is not well ordered.Keywords: nuclear receptor; VDR LBD; ligand binding; conformation; transactivation.Steroids, retinoids, thyroid hormone and vitamin D 3 mediate their pleitoric effects through ligand-dependent transcription factors, the nuclear receptors [1,2]. These receptors control cell growth and differentiation, homeostasis, development and other physiological processes by modulating target genes. Members of the nuclear receptors superfamily exhibit the same modular structure with a variable N-terminal domain (A /B region), a conserved DNA binding domain (DBD, C region), a flexible hinge region (D region) and a moderately conserved ligand binding domain (LBD, E/F region). The A /B region is the most divergent among the nuclear receptors and contains a ligand independent activation function AF-1. The LBD contains a dimerization interface and a ligand-dependent transcriptional activation domain AF-2. The crystallographic structures of ligand binding domains of several liganded and unliganded nuclear receptors (reviewed in [3,4]) have shown that they share a common fold with 11±13 a helices sandwiched' in three layers. Ligand binding induces a conformational change in the orientation of the AF-2 core motif that allows the interaction with coactivators that facilitate the interaction between the nuclear receptor and the basal transcription machinery [3]. Several coactivators [5±7] have been identified as the SRC coactivators family, the DRIP/ TRAP coactivators or cointegrators (CBP/P300). They all present a LXXLL motif, a requirement for the interaction with the AF-2 domain of nuclear receptors. Efficient transcriptional regulation is achieved through the interaction of nuclear receptors with coregulator and the recruitment to the promoter of diverse functional domains responsible of acetylation, deacetylation, phophorylation, ligation or proteolysis [6].The vitamin D nuclear receptor (VDR) mediates the genomic actions upon binding to the active form ...